Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0ZM6R
|
||||
| Former ID |
DNC004348
|
||||
| Drug Name |
2,2,4-Trimethyl-6-phenyl-1,2-dihydro-quinoline
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [534695] | ||
| Formula |
C18H19N
|
||||
| Canonical SMILES |
CC1=CC(NC2=C1C=C(C=C2)C3=CC=CC=C3)(C)C
|
||||
| InChI |
1S/C18H19N/c1-13-12-18(2,3)19-17-10-9-15(11-16(13)17)14-7-5-4-6-8-14/h4-12,19H,1-3H3
|
||||
| InChIKey |
XKBGEVHKVFIMLY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Progesterone receptor | Target Info | Inhibitor | [534695] | |
| KEGG Pathway | Oocyte meiosis | ||||
| Progesterone-mediated oocyte maturation | |||||
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.